144 related articles for article (PubMed ID: 22286881)
1. Predicting response to antiretroviral treatment by machine learning: the EuResist project.
Zazzi M; Incardona F; Rosen-Zvi M; Prosperi M; Lengauer T; Altmann A; Sonnerborg A; Lavee T; Schülter E; Kaiser R
Intervirology; 2012; 55(2):123-7. PubMed ID: 22286881
[TBL] [Abstract][Full Text] [Related]
2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
3. Investigation of expert rule bases, logistic regression, and non-linear machine learning techniques for predicting response to antiretroviral treatment.
Prosperi MC; Altmann A; Rosen-Zvi M; Aharoni E; Borgulya G; Bazso F; Sönnerborg A; Schülter E; Struck D; Ulivi G; Vandamme AM; Vercauteren J; Zazzi M;
Antivir Ther; 2009; 14(3):433-42. PubMed ID: 19474477
[TBL] [Abstract][Full Text] [Related]
4. Learning from past treatments and their outcome improves prediction of in vivo response to anti-HIV therapy.
Saigo H; Altmann A; Bogojeska J; Müller F; Nowozin S; Lengauer T
Stat Appl Genet Mol Biol; 2011; 10():Article 6. PubMed ID: 21291416
[TBL] [Abstract][Full Text] [Related]
5. Development and performance of conventional HIV-1 phenotyping (Antivirogram®) and genotype-based calculated phenotyping assay (virco®TYPE HIV-1) on protease and reverse transcriptase genes to evaluate drug resistance.
Pattery T; Verlinden Y; De Wolf H; Nauwelaers D; Van Baelen K; Van Houtte M; Mc Kenna P; Villacian J
Intervirology; 2012; 55(2):138-46. PubMed ID: 22286884
[TBL] [Abstract][Full Text] [Related]
6. Prediction of response to antiretroviral therapy by human experts and by the EuResist data-driven expert system (the EVE study).
Zazzi M; Kaiser R; Sönnerborg A; Struck D; Altmann A; Prosperi M; Rosen-Zvi M; Petroczi A; Peres Y; Schülter E; Boucher CA; Brun-Vezinet F; Harrigan PR; Morris L; Obermeier M; Perno CF; Phanuphak P; Pillay D; Shafer RW; Vandamme AM; van Laethem K; Wensing AM; Lengauer T; Incardona F
HIV Med; 2011 Apr; 12(4):211-8. PubMed ID: 20731728
[TBL] [Abstract][Full Text] [Related]
7. Impact of genotypic resistance testing on selection of salvage regimen in clinical practice.
Haupts S; Ledergerber B; Böni J; Schüpbach J; Kronenberg A; Opravil M; Flepp M; Speck RF; Grube C; Rentsch K; Weber R; Günthard HF;
Antivir Ther; 2003 Oct; 8(5):443-54. PubMed ID: 14640392
[TBL] [Abstract][Full Text] [Related]
8. Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting.
Zazzi M; Prosperi M; Vicenti I; Di Giambenedetto S; Callegaro A; Bruzzone B; Baldanti F; Gonnelli A; Boeri E; Paolini E; Rusconi S; Giacometti A; Maggiolo F; Menzo S; De Luca A;
J Antimicrob Chemother; 2009 Sep; 64(3):616-24. PubMed ID: 19620134
[TBL] [Abstract][Full Text] [Related]
9. Genotypic resistance tests for the management of the HIV-infected patient with non-B viral isolates.
Visco-Comandini U; Balotta C
Scand J Infect Dis Suppl; 2003; 106():75-8. PubMed ID: 15000590
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral resistance testing for clinical management.
Youree BE; D'Aquila RT
AIDS Rev; 2002; 4(1):3-12. PubMed ID: 11998782
[TBL] [Abstract][Full Text] [Related]
11. Construction, training and clinical validation of an interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules revised by virological outcomes.
De Luca A; Vendittelli M; Baldini F; Di Giambenedetto S; Trotta MP; Cingolani A; Bacarelli A; Gori C; Perno CF; Antinori A; Ulivi G
Antivir Ther; 2004 Aug; 9(4):583-93. PubMed ID: 15456090
[TBL] [Abstract][Full Text] [Related]
12. The application of artificial neural networks for phenotypic drug resistance prediction: evaluation and comparison with other interpretation systems.
Pasomsub E; Sukasem C; Sungkanuparph S; Kijsirikul B; Chantratita W
Jpn J Infect Dis; 2010 Mar; 63(2):87-94. PubMed ID: 20332568
[TBL] [Abstract][Full Text] [Related]
13. Description of two commercially available assays for genotyping of HIV-1.
Stürmer M; Reinheimer C
Intervirology; 2012; 55(2):134-7. PubMed ID: 22286883
[TBL] [Abstract][Full Text] [Related]
14. Genotypic resistance tests for the clinical management of patients with primary HIV infection.
Narciso P; Lazzarin A
Scand J Infect Dis Suppl; 2003; 106():66-70. PubMed ID: 15000588
[TBL] [Abstract][Full Text] [Related]
15. Genotypic drug resistance interpretation systems--the cutting edge of antiretroviral therapy.
Schmidt B; Walter H; Zeitler N; Korn K
AIDS Rev; 2002; 4(3):148-56. PubMed ID: 12416449
[TBL] [Abstract][Full Text] [Related]
16. Variability in the interpretation of transmitted genotypic HIV-1 drug resistance and prediction of virological outcomes of the initial HAART by distinct systems.
De Luca A; Cozzi-Lepri A; Perno CF; Balotta C; Di Giambenedetto S; Poggio A; Pagano G; Tositti G; Piscopo R; Del Forno A; Chiodo F; Magnani G; d'Arminio Monforte A; ;
Antivir Ther; 2004 Oct; 9(5):743-52. PubMed ID: 15535412
[TBL] [Abstract][Full Text] [Related]
17. A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy.
Wang D; Larder B; Revell A; Montaner J; Harrigan R; De Wolf F; Lange J; Wegner S; Ruiz L; Pérez-Elías MJ; Emery S; Gatell J; D'Arminio Monforte A; Torti C; Zazzi M; Lane C
Artif Intell Med; 2009 Sep; 47(1):63-74. PubMed ID: 19524413
[TBL] [Abstract][Full Text] [Related]
18. Algorithms for the interpretation of HIV-1 genotypic drug resistance information.
Vercauteren J; Vandamme AM
Antiviral Res; 2006 Sep; 71(2-3):335-42. PubMed ID: 16782210
[TBL] [Abstract][Full Text] [Related]
19. Clinical use of genotypic and phenotypic drug resistance testing to monitor antiretroviral chemotherapy.
Hanna GJ; D'Aquila RT
Clin Infect Dis; 2001 Mar; 32(5):774-82. PubMed ID: 11229846
[TBL] [Abstract][Full Text] [Related]
20. Incorporating drug-resistance measurements into the clinical management of HIV-1 infection.
Zolopa AR
J Infect Dis; 2006 Sep; 194 Suppl 1():S59-64. PubMed ID: 16921474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
